Human Metabolome Technologies, Inc. (TYO:6090)
625.00
0.00 (0.00%)
Aug 27, 2026, 3:30 PM JST
TYO:6090 Financials Overview
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 1,421 | 1,421 | 1,455 | 1,345 | 1,299 | 1,223 |
Revenue Growth | -2.34% | -2.34% | 8.18% | 3.54% | 6.21% | 8.81% |
Gross Profit Gross Profit Growth | 867 | 867 | 922 | 869 | 859 | 839 |
Operating Income Operating Income Growth | 209 | 209 | 250 | 220 | 211 | 191 |
Net Income Net Income Growth | 200 | 200 | 256 | 243 | 285 | 267 |
Earnings Per Share EPS Growth | 35.64 | 35.64 | 43.59 | 41.10 | 48.26 | 45.25 |
EPS Growth | -18.24% | -18.24% | 6.08% | -14.85% | 6.66% | 360.04% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Advanced Research and Development Support Project Advanced Research and Development Support Project Growth | 1,143 | 1,187 | 1,252 | 1,220 |
Health Care Solution Business Health Care Solution Business Growth | 312 | 158.82 | 47.49 | 2.86 |
Total Total Growth | 1,455 | 1,346 | 1,299 | 1,223 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 1,444 | 1,444 | 1,562 | 1,788 | 1,656 | 1,504 |
Total Debt Total Debt Growth | 103 | 103 | 110 | 225 | 226 | 232 |
Net Cash (Debt) Net Cash Growth | 1,341 | 1,341 | 1,452 | 1,563 | 1,430 | 1,272 |
Net Cash Growth | -7.65% | -7.65% | -7.10% | 9.30% | 12.42% | 16.38% |
Net Cash Per Share Net Cash Per Share Growth | 238.98 | 238.98 | 247.26 | 264.33 | 242.17 | 215.59 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 208 | 208 | 373 | 236 | 284 | 324 |
Capital Expenditures CapEx Growth | -60 | -60 | -148 | -33 | -98 | -142 |
Free Cash Flow Free Cash Flow Growth | 148 | 148 | 225 | 203 | 186 | 182 |
Free Cash Flow Growth | -34.22% | -34.22% | 10.84% | 9.14% | 2.20% | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 61.01% | 61.01% | 63.37% | 64.61% | 66.13% | 68.60% |
Operating Margin | 14.71% | 14.71% | 17.18% | 16.36% | 16.24% | 15.62% |
Pretax Margin | 15.76% | 15.76% | 18.49% | 19.41% | 18.24% | 21.42% |
Profit Margin | 14.07% | 14.07% | 17.59% | 18.07% | 21.94% | 21.83% |
FCF Margin | 10.42% | 10.42% | 15.46% | 15.09% | 14.32% | 14.88% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Dividend Per Share Dividend Per Share Growth | 18.000 | - | 15.000 | 15.000 | 10.000 |
Dividend Per Share Growth | 20.00% | - | 0% | 50.00% | - |
Dividend Yield | 2.94% | - | 2.02% | 2.49% | 1.43% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 17.54 | 17.08 | 17.35 | 15.39 | 15.52 | 16.13 |
Forward PE | - | 30.89 | 30.89 | 30.89 | 30.89 | 27.39 |
P/FCF Ratio | 23.50 | 23.08 | 19.74 | 18.42 | 23.79 | 23.67 |
PS Ratio | 2.45 | 2.40 | 3.05 | 2.78 | 3.41 | 3.52 |